CIA - Collegium Internationionale Allergologicum
29th symposia header
 

Abstract Submission

Abstract Submission Guidelines

Deadline for Late-Breaking Abstract Submission:
4 June 2012

To submit your late-breaking abstract electronically, please click here.

Word Limit– 350 words

The Collegium Internationale Allergologicum invites members and non-members to submit abstracts for review for poster or oral presentation at the 29th Symposium in Jeju Island. 

The following guidelines address key factors that the Collegium Internationale Allergologicum Organizing Committee considers when reviewing abstracts. Attention to these details will assist the Committee in making their decision.

  1. Abstracts should contain a concise statement of the problem under investigation; describe experimental methods used; contain specific findings and data (promises such as “the results to be completed” are not appropriate); and contain conclusions based on the data presented (statistical analyses should be used when appropriate to support the conclusions).
  2. Define all concepts and abbreviations at first use. Do not use abbreviations in the title of the abstract.
  3. Previously published abstracts will NOT be considered.
  4. All abstract presenters will be required to register for the symposium, and pay all registration and travel costs.

Abstract submissions can only be made by Collegium Internationale Allergologicum members, candidates or sponsored non-members

Abstracts can be submitted in the following categories:

Category 1: Genetic and environmental factors in allergic disorders

  • Genetics of allergic disorders
  • Environmental factors in immune disorders
  • Epidemiology: risk and protective factors in allergy

Category 2: Dendritic cells, mast cells, monocytes, neutrophils, eosinophils and basophils

  • Dendritic cells
  • Monocytes/Macrophages
  • Mast cells and basophils
  • Eosinophils and neutrophils

Category 3: Lymphocytes and mediators of immunoregulation

  • Cytokines
  • Chemokines
  • T-Cells and Regulatory T-cells
  • NK and iNKT cells
  • Immunoregulation
  • Adjuvants

Category 4: Food and drug allergies and gastrointestinal disorders

Category 5: Asthma, rhinitis and atopic dermatitis

Category 6: Urticaria, angioedema and anaphylaxis

Category 7: Allergens and diagnosis of allergy

  • Allergens
  • Triggers of allergy
  • Biomarkers of allergy: prognosis, severity and treatment efficacy
  • Diagnostic methodologies

Category 8: Pathophysiology of allergic disorders and inflammation

  • Animal models of allergy
  • Mediators of inflammation
  • Immunoglobulins: roles, receptors, regulation
  • Pathophysiology of the allergic response
  • Inflammation: acute/chronic
  • Nerves and Inflammation

Category 9: Treatment of immune disorders

  • Immunomodulation: strategies for prevention and treatment
  • Allergic diseases
  • Autoimmune diseases
  • Immunodeficiencies
  • Experimental therapeutics

Category 10: Allergen specific immunotherapy

  • SLIT
  • SCIT
  • Novel therapies

Category 11: Networks